{"id":34250,"date":"2025-12-20T20:31:34","date_gmt":"2025-12-20T19:31:34","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&p=34250"},"modified":"2026-04-15T23:50:41","modified_gmt":"2026-04-15T21:50:41","slug":"orforglipron","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/cs\/obchod-produkt\/orforglipron\/","title":{"rendered":"Orforglipron (peror\u00e1ln\u00ed GLP-1) 5 mg 60 kapsl\u00ed"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Orforglipron - co to je a jak to funguje<\/strong><\/h2>

Orforglipron je investi\u010dn\u00ed, peror\u00e1ln\u00ed agonista receptoru GLP-1<\/strong>, kter\u00fd byl vyvinut pro l\u00e9\u010dbu obezita a diabetes 2. typu<\/strong>. Jedn\u00e1 se o l\u00e1tku s malou molekulou, kter\u00e1 nevy\u017eaduje injekce, tak\u017ee ji lze u\u017e\u00edvat jednou denn\u011b ve form\u011b tablet. Tato forma je v\u00fdznamn\u00fdm zlep\u0161en\u00edm oproti klasick\u00fdm agonist\u016fm GLP-1, kte\u0159\u00ed jsou obvykle peptidy a vy\u017eaduj\u00ed podko\u017en\u00ed pod\u00e1n\u00ed. Orforglipron se v\u00e1\u017ee na receptor GLP-1, co\u017e vede ke zv\u00fd\u0161en\u00ed sekrece inzulinu z\u00e1visl\u00e9ho na gluk\u00f3ze, sn\u00ed\u017een\u00ed sekrece glukagonu, zpomalen\u00ed vyprazd\u0148ov\u00e1n\u00ed \u017ealudku, zv\u00fd\u0161en\u00ed pocitu sytosti a sn\u00ed\u017een\u00ed hmotnosti. Z tohoto d\u016fvodu m\u00e1 potenci\u00e1l zlep\u0161it kontrolu glyk\u00e9mie a pomoci p\u0159i sni\u017eov\u00e1n\u00ed hmotnosti u osob s obezitou nebo metabolick\u00fdmi poruchami.<\/p>

Viz tak\u00e9 Retatrutid 4mg reagencie<\/a><\/p>

Orforglipron - koupit?<\/strong><\/h2>

K dne\u0161n\u00edmu dni je GLP1 Orforglipron nen\u00ed ofici\u00e1ln\u011b schv\u00e1len pro prodej jako l\u00e9k<\/strong> v EU, USA nebo Evrop\u011b. L\u00e1tka je st\u00e1le ve f\u00e1zi klinick\u00fdch zkou\u0161ek a je dostupn\u00e1 pouze v USA. v\u00fdzkumn\u00e9 programy a klinick\u00e1 hodnocen\u00ed<\/strong>. Na internetu m\u016f\u017eete naj\u00edt nab\u00eddky na prodej Orforglipronu ozna\u010den\u00e9 jako \u201epro v\u011bdeck\u00fd v\u00fdzkum\u201d nebo \u201epouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely\u201d.\u201d<\/strong>, ale tyto v\u00fdrobky nemaj\u00ed status registrovan\u00e9ho l\u00e9\u010div\u00e9ho p\u0159\u00edpravku, nejsou ur\u010deny pro hum\u00e1nn\u00ed pou\u017eit\u00ed a jejich pou\u017e\u00edv\u00e1n\u00ed se nedoporu\u010duje<\/strong>. N\u00e1kup t\u011bchto \u010dinidel je ur\u010den v\u00fdhradn\u011b pro laborato\u0159e a v\u00fdzkumn\u00e1 pracovi\u0161t\u011b pro v\u011bdeck\u00e9 a analytick\u00e9 \u00fa\u010dely a tyto v\u00fdrobky nejsou ur\u010deny pro pou\u017eit\u00ed u lid\u00ed ani pro l\u00e9\u010debn\u00e9 \u00fa\u010dely.<\/p>

Orforglipron - cena<\/strong><\/h2>

Proto\u017ee Orforglipron GLP-1 nen\u00ed dosud schv\u00e1len\u00fdm l\u00e9kem<\/strong>, neexistuj\u00ed \u017e\u00e1dn\u00e9 ofici\u00e1ln\u00ed l\u00e9k\u00e1rensk\u00e9 cen\u00edky ani cen\u00edky \u00fahrad. Nicm\u00e9n\u011b na internetu - mimo trh se schv\u00e1len\u00fdmi l\u00e9\u010div\u00fdmi p\u0159\u00edpravky<\/strong> - p\u0159\u00edpravky zn\u00e1m\u00e9 jako Orforglipron lze nal\u00e9zt ve form\u011b v\u00fdzkumn\u00fdch \u010dinidel (v\u00fdzkumn\u00fdch chemik\u00e1li\u00ed). Tyto p\u0159\u00edpravky prod\u00e1vaj\u00ed r\u016fzn\u00e9 laboratorn\u00ed obchodn\u00ed s\u00edt\u011b a jejich ceny se li\u0161\u00ed, nap\u0159. p\u0159ibli\u017en\u011b. 299 USD za balen\u00ed ozna\u010den\u00e9 jako tablety Orforglipron.<\/strong> nab\u00edzen\u00e9 n\u011bkter\u00fdmi internetov\u00fdmi obchody (co\u017e nen\u00ed potvrzen\u00edm kvality, bezpe\u010dnosti nebo legitimn\u00edho prodeje jako l\u00e9ku). Tato cena neodr\u00e1\u017e\u00ed n\u00e1klady na l\u00e9\u010dbu, ale pouze n\u00e1klady na n\u00e1kup v\u00fdzkumn\u00e9ho \u010dinidla, kter\u00e9 nen\u00ed l\u00e9kem schv\u00e1len\u00fdm pro l\u00e9\u010dbu lid\u00ed.<\/p>

Orforglipron - jak u\u017e\u00edvat \/ d\u00e1vkov\u00e1n\u00ed podle studie<\/strong><\/h2>

Peror\u00e1ln\u00ed GLP-1 Orfoglipron nem\u00e1 schv\u00e1len\u00e9 terapeutick\u00e9 d\u00e1vkov\u00e1n\u00ed, proto\u017ee st\u00e1le nen\u00ed registrovan\u00fdm l\u00e9\u010div\u00fdm p\u0159\u00edpravkem a jeho v\u0161echny pou\u017eit\u00e9 informace o d\u00e1vkov\u00e1n\u00ed poch\u00e1zej\u00ed pouze z klinick\u00fdch studi\u00ed f\u00e1ze 2 a f\u00e1ze 3.<\/strong>. B\u011bhem t\u011bchto studi\u00ed byl orfoglipron pod\u00e1v\u00e1n peror\u00e1ln\u011b jednou denn\u011b a mohl b\u00fdt u\u017e\u00edv\u00e1n nez\u00e1visle na j\u00eddle, bez zvl\u00e1\u0161tn\u00edch doporu\u010den\u00ed pro pop\u00edjen\u00ed. Studie hodnotily d\u00e1vky 3 mg, 6 mg, 12 mg a 36 mg denn\u011b.<\/strong>, p\u0159i\u010dem\u017e se pozoruje jasn\u00fd vztah mezi d\u00e1vkou a \u00fa\u010dinkem. Vy\u0161\u0161\u00ed d\u00e1vky byly spojeny s v\u011bt\u0161\u00edm sn\u00ed\u017een\u00edm hmotnosti a lep\u0161\u00ed kontrolou glyk\u00e9mie, ale z\u00e1rove\u0148 \u010dast\u011bji zp\u016fsobovaly gastrointestin\u00e1ln\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky. V n\u011bkter\u00fdch studi\u00edch bylo ke zlep\u0161en\u00ed sn\u00e1\u0161enlivosti l\u00e9\u010dby pou\u017eito postupn\u00e9 zvy\u0161ov\u00e1n\u00ed d\u00e1vky.<\/p>

Orforglipron - vedlej\u0161\u00ed \u00fa\u010dinky a bezpe\u010dnost pou\u017eit\u00ed<\/strong><\/h2>

Dostupn\u00e9 \u00fadaje z klinick\u00fdch studi\u00ed nazna\u010duj\u00ed, \u017ee bezpe\u010dnostn\u00ed profil GLP-1 p\u0159\u00edpravku Orforglipron je podobn\u00fd ostatn\u00edm agonist\u016fm GLP-1.<\/strong> z hlediska b\u011b\u017en\u00fdch ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f. Nej\u010dast\u011bji pozorovan\u00fdmi ne\u017e\u00e1douc\u00edmi \u00fa\u010dinky byly gastrointestin\u00e1ln\u00ed obt\u00ed\u017ee, jako nap\u0159. nevolnost, pr\u016fjem, z\u00e1cpa, plynatost nebo zvracen\u00ed.<\/strong>. Ve v\u011bt\u0161in\u011b p\u0159\u00edpad\u016f byly tyto \u010dinnosti m\u00edrn\u00e1 nebo st\u0159edn\u011b t\u011b\u017ek\u00e1<\/strong> a s pokra\u010duj\u00edc\u00ed l\u00e9\u010dbou se \u010dasto sni\u017euje. \u00dapln\u00fd bezpe\u010dnostn\u00ed profil l\u00e9ku se st\u00e1le hodnot\u00ed ve studi\u00edch f\u00e1ze 3, kter\u00e9 zahrnuj\u00ed tak\u00e9 anal\u00fdzu metabolick\u00fdch parametr\u016f a potenci\u00e1ln\u00edch kardiometabolick\u00fdch p\u0159\u00edhod.<\/p>

\"Orforglipron<\/a><\/p>

Zdroje informac\u00ed:<\/strong><\/p>

New England Journal of Medicine (2023)<\/strong>
Studie f\u00e1ze 2 hodnot\u00edc\u00ed \u00fa\u010dinnost a bezpe\u010dnost peror\u00e1ln\u00edho orfoglipronu u ob\u00e9zn\u00edch osob.
https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2302392<\/a><\/p>

The Lancet \/ PubMed (2023)<\/strong>
Multicentrick\u00e1 randomizovan\u00e1 studie f\u00e1ze 2 u pacient\u016f s diabetem 2. typu, kter\u00e1 analyzuje vztah mezi d\u00e1vkou a \u00fa\u010dinkem a sn\u00e1\u0161enlivost l\u00e9\u010dby.
https:\/\/pubmed.ncbi.nlm.nih.gov\/37369232\/<\/a><\/p>

New England Journal of Medicine (2025)<\/strong>
Studie f\u00e1ze 3 hodnot\u00edc\u00ed sn\u00ed\u017een\u00ed hmotnosti, kardiometabolick\u00e9 parametry a bezpe\u010dnost orfogliprone.
https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2511774<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Orfoglipron je nov\u00e1 peror\u00e1ln\u00ed mal\u00e1 molekula, kter\u00e1 p\u0159itahuje zna\u010dn\u00fd z\u00e1jem v\u011bdeck\u00e9 komunity d\u00edky sv\u00e9mu potenci\u00e1lu ve studi\u00edch regulace chuti k j\u00eddlu, kontroly hmotnosti a metabolismu gluk\u00f3zy a inzul\u00ednu.<\/p>","protected":false},"featured_media":34002,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[130,135,15],"product_tag":[137],"class_list":{"0":"post-34250","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-produkty-w-kapsulkach-tabletkach","7":"product_cat-produkty-w-kapsulkach","8":"product_cat-laboratory-research","9":"product_tag-kapsulki","11":"first","12":"instock","13":"sale","14":"shipping-taxable","15":"purchasable","16":"product-type-simple"},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/comments?post=34250"}],"version-history":[{"count":11,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34250\/revisions"}],"predecessor-version":[{"id":35432,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34250\/revisions\/35432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media\/34002"}],"wp:attachment":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media?parent=34250"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_brand?post=34250"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_cat?post=34250"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_tag?post=34250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}